The activation mechanism of chimeric antigen receptor (CAR)-engineered T cells may differ substantially from T cells carrying native T cell receptor,but this difference remains poorly understood. We present the first ...The activation mechanism of chimeric antigen receptor (CAR)-engineered T cells may differ substantially from T cells carrying native T cell receptor,but this difference remains poorly understood. We present the first comprehensive portrait of single-cell level transcriptional and cyto-kine signatures of anti-CD19/4-1BB/CD28/CD3ζ CAR-T cells upon antigen-specific stimulation. Both CD4+helper T (TH) cells and CD8+cytotoxic CAR-T cells are equally effective in directly killing target tumor cells and their cytotoxic activity is associated with the elevation of a range of TH1 and TH2 signature cytokines,e.g.,interferon γ,tumor necrotic factor α,interleukin 5 (IL5),and IL13,as confirmed by the expression of master transcription factor genes TBX21 and GATA3. However,rather than conforming to stringent TH1 or TH2 subtypes,single-cell analysis reveals that the predominant response is a highly mixed TH1/TH2 function in the same cell. The reg-ulatory T cell activity,although observed in a small fraction of activated cells,emerges from this hybrid TH1/TH2 population. Granulocyte-macrophage colony stimulating factor (GM-CSF) is pro-duced from the majority of cells regardless of the polarization states,further contrasting CAR-T to classic T cells. Surprisingly,the cytokine response is minimally associated with differentiation status,although all major differentiation subsets such as na?ve,central memory,effector memory,and effector are detected. All these suggest that the activation of CAR-engineered T cells is a canon-ical process that leads to a highly mixed response combining both type 1 and type 2 cytokines together with GM-CSF,supporting the notion that polyfunctional CAR-T cells correlate with objective response of patients in clinical trials. This work provides new insights into the mechanism of CAR activation and implies the necessity for cellular function assays to characterize the quality of CAR-T infusion products and monitor therapeutic responses in patients.展开更多
The past years have witnessed significant advance in our understanding of critical roles of T cell co-signals in B7-CD28 family molecules in regulating T cell activation and tolerance.New co-signaling molecules have b...The past years have witnessed significant advance in our understanding of critical roles of T cell co-signals in B7-CD28 family molecules in regulating T cell activation and tolerance.New co-signaling molecules have been identified and their functions have been delineated.These co-signaling pathways play overlapping and distinct regulatory roles at various stages of a T cell response.By expressing in appropriate time and location,these pathways have different regulatory functions through independent receptors or on different subsets of lymphocytes.Precise understanding of these pathways will allow the development of novel approaches to treatment of human diseases such as cancer,viral infection,autoimmune diseases and transplantation rejection. Cellular & Molecular Immunology.2004;1(1):37-42.展开更多
Increased expression of Fas by hematopoietic progenitors in aplastic anemia(AA)suggests that Fas/Fas ligand (FasL)system plays a key role in the formation of severe pancytopenia.To further confirm the above hypo- thes...Increased expression of Fas by hematopoietic progenitors in aplastic anemia(AA)suggests that Fas/Fas ligand (FasL)system plays a key role in the formation of severe pancytopenia.To further confirm the above hypo- thesis,T cells from 8 patients with AA were systematically studied for their FasL's distribution pattern, releasing manner and proapoptotic activity,compared with normal resting T cells and artificially activated T cell blasts.The results demonstrated that AA T cells abnormally expressed low levels of membrane-bound FasL and contained high levels of intracellular FasL which could be triggered to release by high-dose phyto- hemagglutinin(PHA)pulse-stimulation.The supernatants from the PHA-stimulated AA T cells had apparent cytotoxicity against FasL-sensitive Jurkat cells,which could be significantly inhibited by monocional antibody against FasL in a dose-dependent manner,or nearly completely abrogated by ultracentrifugation.The above phenomena also appeared on artificially activated T cell blasts,but this was not the case on normal resting T cells.These results indicate that AA T cell is a type of“preactivated”T lymphocyte,characterized by over- expression of FasL,especially intracellular FasL which can be stimulated to release in bioavtive exosomes- bound form.Taken together,our data provide further and direct evidence for the hypothesis that T cells might mediate the destruction of hematopietic progenitor in AA through Fas/FasL system.Cellular & Molecular Immunology.2004;1(2):142-147.展开更多
基金supported by the Packard Fellowship for Science and Engineering, the CAREER award from the National Science Foundation (NSF), United States (Grant No. CBET-1351443)the grants from National Institutes of Health (NIH), United States (Grant No. U54 CA193461 and Sub-Project 7297 of Grant No. U54 CA209992)+1 种基金the CoPilot Grant from Yale Cancer Center, United States, to RFsupported by National Institutes of Health, United States (NIH U54DK106857)
文摘The activation mechanism of chimeric antigen receptor (CAR)-engineered T cells may differ substantially from T cells carrying native T cell receptor,but this difference remains poorly understood. We present the first comprehensive portrait of single-cell level transcriptional and cyto-kine signatures of anti-CD19/4-1BB/CD28/CD3ζ CAR-T cells upon antigen-specific stimulation. Both CD4+helper T (TH) cells and CD8+cytotoxic CAR-T cells are equally effective in directly killing target tumor cells and their cytotoxic activity is associated with the elevation of a range of TH1 and TH2 signature cytokines,e.g.,interferon γ,tumor necrotic factor α,interleukin 5 (IL5),and IL13,as confirmed by the expression of master transcription factor genes TBX21 and GATA3. However,rather than conforming to stringent TH1 or TH2 subtypes,single-cell analysis reveals that the predominant response is a highly mixed TH1/TH2 function in the same cell. The reg-ulatory T cell activity,although observed in a small fraction of activated cells,emerges from this hybrid TH1/TH2 population. Granulocyte-macrophage colony stimulating factor (GM-CSF) is pro-duced from the majority of cells regardless of the polarization states,further contrasting CAR-T to classic T cells. Surprisingly,the cytokine response is minimally associated with differentiation status,although all major differentiation subsets such as na?ve,central memory,effector memory,and effector are detected. All these suggest that the activation of CAR-engineered T cells is a canon-ical process that leads to a highly mixed response combining both type 1 and type 2 cytokines together with GM-CSF,supporting the notion that polyfunctional CAR-T cells correlate with objective response of patients in clinical trials. This work provides new insights into the mechanism of CAR activation and implies the necessity for cellular function assays to characterize the quality of CAR-T infusion products and monitor therapeutic responses in patients.
文摘The past years have witnessed significant advance in our understanding of critical roles of T cell co-signals in B7-CD28 family molecules in regulating T cell activation and tolerance.New co-signaling molecules have been identified and their functions have been delineated.These co-signaling pathways play overlapping and distinct regulatory roles at various stages of a T cell response.By expressing in appropriate time and location,these pathways have different regulatory functions through independent receptors or on different subsets of lymphocytes.Precise understanding of these pathways will allow the development of novel approaches to treatment of human diseases such as cancer,viral infection,autoimmune diseases and transplantation rejection. Cellular & Molecular Immunology.2004;1(1):37-42.
基金supported by grants from National Key Basic Research Program of China("973"project)(No.2001CB510003)Basic scientific research program foundation of the Commission of Science Technology an d Industry for National Defence(2003-44)Key Medical Elite Foundation of Jiangsu Provincial Govemment(No.RC2002021)
文摘Increased expression of Fas by hematopoietic progenitors in aplastic anemia(AA)suggests that Fas/Fas ligand (FasL)system plays a key role in the formation of severe pancytopenia.To further confirm the above hypo- thesis,T cells from 8 patients with AA were systematically studied for their FasL's distribution pattern, releasing manner and proapoptotic activity,compared with normal resting T cells and artificially activated T cell blasts.The results demonstrated that AA T cells abnormally expressed low levels of membrane-bound FasL and contained high levels of intracellular FasL which could be triggered to release by high-dose phyto- hemagglutinin(PHA)pulse-stimulation.The supernatants from the PHA-stimulated AA T cells had apparent cytotoxicity against FasL-sensitive Jurkat cells,which could be significantly inhibited by monocional antibody against FasL in a dose-dependent manner,or nearly completely abrogated by ultracentrifugation.The above phenomena also appeared on artificially activated T cell blasts,but this was not the case on normal resting T cells.These results indicate that AA T cell is a type of“preactivated”T lymphocyte,characterized by over- expression of FasL,especially intracellular FasL which can be stimulated to release in bioavtive exosomes- bound form.Taken together,our data provide further and direct evidence for the hypothesis that T cells might mediate the destruction of hematopietic progenitor in AA through Fas/FasL system.Cellular & Molecular Immunology.2004;1(2):142-147.
